Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Mona H. Haron, Bharathi Avula, Zulfiqar Ali, Amar G. Chittiboyina, Ikhlas A. Khan, Jing Li, Vivian Wang, Charles Wu & Shabana I. Khan. (2023) Assessment of Herb-Drug Interaction Potential of Five Common Species of Licorice and Their Phytochemical Constituents. Journal of Dietary Supplements 20:4, pages 582-601.
Read now
Read now
Mona H. Haron, Bharathi Avula, PhD, Bill J. Gurley, PhD, Amar G. Chittiboyina, PhD, Ikhlas A. Khan, PhD & Shabana I. Khan, PhD. (2022) Possible Herb-Drug Interaction Risk of Some Nutritional and Beauty Supplements on Antiretroviral Therapy in HIV Patients. Journal of Dietary Supplements 19:1, pages 62-77.
Read now
Read now
Amedeo F. Capetti, Maria V. Cossu, Laura Paladini & Giuliano Rizzardini. (2018) Dolutegravir plus rilpivirine dual therapy in treating HIV-1 infection. Expert Opinion on Pharmacotherapy 19:1, pages 65-77.
Read now
Read now
Rana Zainuddin, Zahid Zaheer, Jaiprakash N. Sangshetti & Mufassir Momin. (2017) Enhancement of oral bioavailability of anti-HIV drug rilpivirine HCl through nanosponge formulation. Drug Development and Industrial Pharmacy 43:12, pages 2076-2084.
Read now
Read now
Amedeo F. Capetti, Noemi Astuti, Dario Cattaneo & Giuliano Rizzardini. (2017) Pharmacokinetic drug evaluation of dolutegravir plus rilpivirine for the treatment of HIV. Expert Opinion on Drug Metabolism & Toxicology 13:11, pages 1183-1192.
Read now
Read now
W. Spreen, S. Min, S. L. Ford, S. Chen, Y. Lou, M. Bomar, M. St Clair, S. Piscitelli & T. Fujiwara. (2013) Pharmacokinetics, Safety, and Monotherapy Antiviral Activity of GSK1265744, an HIV Integrase Strand Transfer Inhibitor. HIV Clinical Trials 14:5, pages 192-203.
Read now
Read now
Janice Soo Fern Lee, Alexandra Calmy, Isabelle Andrieux-Meyer & Nathan Ford. (2012) Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settings. HIV/AIDS - Research and Palliative Care 4, pages 5-15.
Read now
Read now
Articles from other publishers (8)
Sandra Grañana-Castillo, Maiara Camotti Montanha, Rachel Bearon, Saye Khoo & Marco Siccardi. (2022) Evaluation of drug-drug interaction between rilpivirine and rifapentine using PBPK modelling. Frontiers in Pharmacology 13.
Crossref
Crossref
Sivagami BSharmil Kumar. L.MChandrasekar. RNiranjan Babu. M. (2022) Development and Validation for the Simultaneous Estimation of Rilpivirine and Dolutegravir in Bulk and Pharmaceutical Dosage Forms by RP-HPLC Method. Research Journal of Pharmacy and Technology, pages 5302-5306.
Crossref
Crossref
Spencer H. Durham & Elias B. Chahine. (2021) Cabotegravir-Rilpivirine: The First Complete Long-Acting Injectable Regimen for the Treatment of HIV-1 Infection. Annals of Pharmacotherapy 55:11, pages 1397-1409.
Crossref
Crossref
Amedeo De Nicolò, Alice Ianniello, Micol Ferrara, Valeria Avataneo, Jessica Cusato, Miriam Antonucci, Elisa De Vivo, Catriona Waitt, Andrea Calcagno, Alice Trentalange, Giampiero Muccioli, Stefano Bonora, Giovanni Di Perri & Antonio D'Avolio. (2020) Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV. Pharmaceuticals 14:1, pages 12.
Crossref
Crossref
Daniel M. Himmel & Eddy Arnold. (2020) Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV. Pharmaceuticals 13:6, pages 122.
Crossref
Crossref
Madhuri Manchala, Vijaya Sri Kanagala & Ganapath Vinay Jain. (2015) DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR RILPIVIRINE HYDROCHLORIDE IN BULK AND USE IN ANALYSIS OF PREPARED NANOSUSPENSION. INDIAN DRUGS 52:04, pages 42-46.
Crossref
Crossref
Ajay Gupta, Swati Guttikar, Yogesh Patel, Pranav S. Shrivastav & Mallika Sanyal. (2015) Reliable LC-MS/MS assay for the estimation of rilpivirine in human plasma: application to a bioequivalence study and incurred sample reanalysis. Drug Testing and Analysis 7:4, pages 290-299.
Crossref
Crossref
Laxminarayana Burugula, Nageswara Rao Pilli, Ajitha Makula, Durga Srinivas Lodagala & Rajnarayana Kandhagatla. (2013) Liquid chromatography-tandem mass spectrometric assay for the non-nucleoside reverse transcriptase inhibitor rilpivirine in human plasma. Biomedical Chromatography 27:2, pages 172-178.
Crossref
Crossref